Research
Blood based multi biomarker panel discriminates Alzheimer disease from healthy controls in a single center nested cross validation
Nature ·
The Brief
- A blood-based multi-biomarker panel was tested for distinguishing Alzheimer disease from healthy controls.
- The evaluation used a single-center nested cross-validation design.
- The source provides only the title and feed listing, so no performance figures are available here.
Why it matters
Blood-based biomarkers could eventually offer a less invasive way to screen for Alzheimer disease, but results from one center under cross-validation still need independent validation before clinical use.
Who’s affected
- researchers working on Alzheimer disease biomarkers
- clinicians and scientists interested in blood-based diagnostics
- #alzheimer
- #biomarkers
- #blood test
- #diagnostics
- #cross-validation
Timeline
Article listed in nature.com biological sciences subject feed
Biological sciences : nature.com subject feeds
Blood based multi biomarker panel discriminates Alzheimer disease from healthy controls in a single center nested cross validation